| dbo:abstract
|
- The Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umeå University was established in 2007 as a joint venture between the European Molecular Biology Laboratory (EMBL) and the Nordic EMBL Partnership for Molecular Medicine, Heidelberg. Additional partners in the Nordic region are the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and the Centre for Molecular Medicine Norway (NCMM) at the University of Oslo. The Danish Research Institute of Translational Neuroscience (DANDRITE) at the Aarhus University has also joined the collaboration. MIMS at Umeå University is a part of the , which also includes researchers in molecular biology and clinical microbiology, chemistry and physics, and is closely connected to the University Hospital of Umeå (NUS). Since 2014 MIMS coordinates the National Doctoral Programme in Infections and Antibiotics (NDPIA), funded by the Swedish Research Council (Vetenskapsrådet). Founding director of MIMS is , professor of molecular infection medicine and award-winner of the Göran Gustafsson Prize in Molecular Biology 1995. He was also awarded the Umeå University’s Medal of Honour in 2015, the highest distinction that is awarded to an individual at the university. Bernt Eric Uhlin is awarded the medal for his outstanding contribution to the university and the development of the strong research environment within infection biology and molecular infection medicine. Oliver Billker, a distinguished expert in malaria parasite genomics, was appointed as new director of MIMS in October 2018 and succeeded Bernt Eric Uhlin. Among the approximately 15 researcher groups, one stands out in particular: the award winner of the Göran Gustafsson Prize 2014 in Molecular Biology Emmanuelle Charpentier’s group, which has studied “Molecular mechanisms governing Gram-positive bacterial pathogenesis” and was the driving force behind the discovery of the mechanisms behind the CRISPR-Cas9 system. (en)
- Laboratoriet för molekylär infektionsmedicin Sverige (MIMS) vid Umeå universitet är sedan 2007 den svenska noden i det nordiska EMBL-partnerskapet för molekylär medicin, och i det sameuropeiska molekylärbiologiska laboratoriet (EMBL) i Heidelberg. Övriga partners i Norden är Institute for Molecular Medicine Finland (FIMM) vid i Helsingfors universitet och Centre for Molecular Medicine Norway (NCMM) vid Oslo universitet. Senare har även Danish Research Institute of Translational Neuroscience (DANDRITE) i Århus anslutit sig till samarbetet. Vid Umeå universitet är MIMS en del av Umeå Centre for Microbial Research (UCMR), som också inkluderar forskare inom molekylärbiologi och klinisk mikrobiologi, kemi och fysik, och har ett nära samarbete med det närbelägna Norrlands universitetssjukhus (NUS). Sedan 2014 koordinerar MIMS den Nationella forskarskolan inom infektion och antibiotika (NDPIA), som finansieras av Vetenskapsrådet och 2017 fick bidragsperioden förlängd till 2021. MIMS åren 2007–2018 var Bernt Eric Uhlin, professor i molekylär infektionsmedicin, Göran Gustafsson-pristagare i molekylär biologi 1995. Han efterträds 1 oktober 2018 av , forskningsledare vid Wellcome Trust Sanger Institute i Cambridge, Storbritannien. Bland ett 20-tal forskargrupper märks 2014 års Göran Gustafsson-pristagare i molekylär biologi Emmanuelle Charpentiers grupp, som forskar om de mekanismer som reglerar infektioner och immunitet, och bland annat varit drivande bakom upptäckten av mekanismerna bakom CRISPR-Cas9-systemet. (sv)
|
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4323 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:city
| |
| dbp:established
| |
| dbp:head
| |
| dbp:headLabel
| |
| dbp:name
|
- The Laboratory for Molecular Infection Medicine Sweden (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- The Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umeå University was established in 2007 as a joint venture between the European Molecular Biology Laboratory (EMBL) and the Nordic EMBL Partnership for Molecular Medicine, Heidelberg. Additional partners in the Nordic region are the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and the Centre for Molecular Medicine Norway (NCMM) at the University of Oslo. The Danish Research Institute of Translational Neuroscience (DANDRITE) at the Aarhus University has also joined the collaboration. (en)
- Laboratoriet för molekylär infektionsmedicin Sverige (MIMS) vid Umeå universitet är sedan 2007 den svenska noden i det nordiska EMBL-partnerskapet för molekylär medicin, och i det sameuropeiska molekylärbiologiska laboratoriet (EMBL) i Heidelberg. Övriga partners i Norden är Institute for Molecular Medicine Finland (FIMM) vid i Helsingfors universitet och Centre for Molecular Medicine Norway (NCMM) vid Oslo universitet. Senare har även Danish Research Institute of Translational Neuroscience (DANDRITE) i Århus anslutit sig till samarbetet. (sv)
|
| rdfs:label
|
- Molecular Infection Medicine Sweden (en)
- Molecular Infection Medicine Sweden (sv)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
